Monday, March 4, 2024
HomeBreaking NewsRedHill Biopharma Announces FDA Grant of 5-Year U.S. Market Exclusivity for Talicia®...

RedHill Biopharma Announces FDA Grant of 5-Year U.S. Market Exclusivity for Talicia® with IP Protection Running to 2034

Most Popular

Advertisement

Subscribe to our Stock News Alerts

Mobile is not required however if you want the fastest
delivery be sure to add your mobile.

Subscribe to our News Alerts
Loading